Bioequivalence and Bioavailability Forum 09:30 CEST

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Helmut
Hero
avatar
Homepage
Vienna, Austria,
2018-07-16 14:49

Posting: # 19065
Views: 454
 

 ICH M9 Draft [BE/BA News]

Dear all,

on 27 June the ICH released the draft guideline

Biopharmaceutics Classification System-based Biowaivers (M9, step 2).

Public consultation is planned for August 2018 and adoption of the final guideline in May 2019.

I’m wondering how this guideline was developed where one of the founding members of ICH (Japan) does not accept BCS-based biowaivers at all… :confused:

Cheers,
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. ☼
Science Quotes
Activity
 Thread view
Bioequivalence and Bioavailability Forum |  Admin contact
18,782 posts in 4,002 threads, 1,260 registered users;
online 26 (0 registered, 26 guests [including 19 identified bots]).

To propose that poor design can be corrected by subtle analysis techniques
is contrary to good scientific thinking.    Stuart J. Pocock

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed